John B. Moriarty, EVP & General Counsel at ALEXION PHARMACEUTICALS INC (ALXN), sold 6,918 shares at $125.69 ($870K) on 2017-02-06, disclosed to the SEC on 2017-02-08.
Seasonal sale ($870k) by EVP & General Counsel — this insider has traded ALXN in February in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $125.69 | 3,380 | $425K | 48.8% |
| 2 | $125.69 | 3,380 | $425K | 48.8% |
| 3 | $126.38 | 23 | $3K | 0.3% |
| 4 | $128.09 | 135 | $17K | 2.0% |
| Total | $125.74 avg | 6,918 | $870K | 100% |
| Filing → |
| ALXN | SELL | 2018-02-08 | $639K | — | Filing → |
| ALXN | SELL | 2018-02-07 | $296K | — | Filing → |
| ALXN | SELL | 2017-03-01 | $438K | — | Filing → |